Oct 20 (Reuters) – Verrica Pharmaceuticals Inc: * VERRICA PHARMACEUTICALS RECEIVES POSITIVE FEEDBACK FROM THE EUROPEAN MEDICINES AGENCY (EMA) SUPPORTING A CLEAR REGULATORY PATH FORWARD TO FILE FOR APPROVAL OF YCANTH® IN THE EUROPEAN UNION * VERRICA PHARMACEUTICALS INC – PLANS REGULATORY SUBMISSION FOR YCANTH BY Q4 2026 Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Washington (dpa) - A new analysis has found evidence of liquid on Pluto's surface, NASA…
In the latest installment of Lee Child’s best-selling series, a chance encounter with a distraught…
By Danielle Broadway LOS ANGELES, Aug 11 (Reuters) - The culturally diverse girl group KATSEYE,…
By Danielle Broadway LOS ANGELES, Aug 11 (Reuters) - The culturally diverse girl group KATSEYE,…
Don't sit there sweating in your smart suit when temperatures are soaring outside. Linen is…
By Danielle Kaye and Joyce Zhou NEW YORK/HONG KONG, Aug 11 (Reuters) - Taylor Swift's…